Literature DB >> 27444702

Immunohistochemical assessment of cell populations in leprosy-spectrum lesions and reactional forms.

Luciana Raquel Vincenzi Fachin1, Cleverson Teixeira Soares2, Andrea de Faria Fernandes Belone1, Ana Paula Favaro Trombone3, Patrícia Sammarco Rosa4, Cássio Cesar Guidella5, Marcello Fabiano Franco6.   

Abstract

In situ immunophenotyping of leprosy lesions can improve our understanding of the biology of inflammatory cells during the immune response to Mycobacterium leprae antigens. In the present study, biopsies from 10 healthy controls and 70 leprosy patients were selected, 10 for each of the following conditions: clinical tuberculoid (TT), borderline tuberculoid (BT), borderline borderline (BB), borderline lepromatous (BL), lepromatous (LL), reversal reaction (R1), and erythema nodosum leprosum (R2). Qualitative and quantitative immunohistochemical analyses were performed to detect CD3, CD4, CD8, FoxP3, CD20, CD138, CD1a, CD57, CD15, CD117, CD68, and CD163. In addition, histochemistry was employed to identify eosinophils. The amount of CD3+ and CD4+ T cells was higher in TT than in LL patients. CD8+ T cells were predominant in T lymphocyte infiltrations in the basal layer of the epidermis. The number of FoxP3+ cells was similar among different forms of the disease, but was higher in BL and LL than in R2 individuals. CD20+ lymphocytes were most abundant in TT samples, while CD138+ plasma cells displayed no detectable differences. Epithelioid macrophages from the center of TT and R1 granulomas exhibited the M1 phenotype (CD68+CD163-), whereas those in LL granulomas showed the M2 phenotype (CD68+CD163+). There was a gradual decrease in the amount of CD1a+ cells from the TT towards the LL form of the disease. A significant increase in the number of neutrophils was observed only in R2 samples. All the cells investigated, except eosinophils, participated in the immunopathogenesis of leprosy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27444702     DOI: 10.14670/HH-11-804

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  8 in total

1.  Characterization of MicroRNA Expression Profiles and Identification of Potential Biomarkers in Leprosy.

Authors:  Karina T O S Jorge; Renan P Souza; Marieta T A Assis; Marcelo G Araújo; Massimo Locati; Amélia M R Jesus; Ida M F Dias Baptista; Cristiano X Lima; Antônio L Teixeira; Mauro M Teixeira; Frederico M Soriani
Journal:  J Clin Microbiol       Date:  2017-03-08       Impact factor: 5.948

2.  Simultaneous analysis of multiple T helper subsets in leprosy reveals distinct patterns of Th1, Th2, Th17 and Tregs markers expression in clinical forms and reactional events.

Authors:  Michelle de Campos Soriani Azevedo; Heloisa Marques; Larissa Sarri Binelli; Mariana Silva Vieira Malange; Amanda Carreira Devides; Eliane Aparecida Silva; Luciana Raquel Vincenzi Fachin; Cassio Cesar Ghidella; Cleverson Teixeira Soares; Gustavo Pompermaier Garlet; Patrícia Sammarco Rosa; Andrea de Farias Fernandes Belone; Ana Paula Favaro Trombone
Journal:  Med Microbiol Immunol       Date:  2017-09-05       Impact factor: 3.402

Review 3.  Leprosy: clinical and immunopathological characteristics.

Authors:  Luis Alberto Ribeiro Froes; Mirian Nacagami Sotto; Maria Angela Bianconcini Trindade
Journal:  An Bras Dermatol       Date:  2022-04-02       Impact factor: 2.113

Review 4.  Leprosy As a Complex Infection: Breakdown of the Th1 and Th2 Immune Paradigm in the Immunopathogenesis of the Disease.

Authors:  Jorge Rodrigues de Sousa; Mirian Nacagami Sotto; Juarez Antonio Simões Quaresma
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

5.  In situ T regulatory cells and Th17 cytokines in paired samples of leprosy type 1 and type 2 reactions.

Authors:  Maurício Barcelos Costa; Emerith Mayra Hungria; Aline Araújo Freitas; Ana Lúcia O M Sousa; Juliano Jampietro; Fernando A Soares; Mariane M A Stefani
Journal:  PLoS One       Date:  2018-06-08       Impact factor: 3.240

6.  Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction.

Authors:  Cleverson T Soares; Luciana R V Fachin; Ana P F Trombone; Patricia S Rosa; Cássio C Ghidella; Andrea F F Belone
Journal:  Front Med (Lausanne)       Date:  2018-09-24

Review 7.  Progress of the Art of Macrophage Polarization and Different Subtypes in Mycobacterial Infection.

Authors:  Gai Ge; Haiqin Jiang; Jingshu Xiong; Wenyue Zhang; Ying Shi; Chenyue Tao; Hongsheng Wang
Journal:  Front Immunol       Date:  2021-11-09       Impact factor: 7.561

Review 8.  Innate Immune Responses in Leprosy.

Authors:  Roberta Olmo Pinheiro; Veronica Schmitz; Bruno Jorge de Andrade Silva; André Alves Dias; Beatriz Junqueira de Souza; Mayara Garcia de Mattos Barbosa; Danuza de Almeida Esquenazi; Maria Cristina Vidal Pessolani; Euzenir Nunes Sarno
Journal:  Front Immunol       Date:  2018-03-28       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.